Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Downgrades Avantor to Market Perform, Lowers Price Target to $28

Cowen & Co. analyst Dan Brennan downgrades Avantor (NYSE:AVTR) from Outperform to Market Perform and lowers the price target from $39 to $28.
byBenzinga Newsdesk
September 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cowen & Co. analyst Dan Brennan downgrades Avantor (NYSE:AVTR) from Outperform to Market Perform and lowers the price target from $39 to $28.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Acer Therapeutics Announces University Of North Carolina Receives $3M Department Of Defense Grant To Support The Proposed Investigator Sponsored OASIS Trial Of ACER-801 To Reduce the Frequency And Severity Of Post-Traumatic Stress Disorder

By Benzinga Newsdesk
October 6, 8:35 AM
$3 million awarded to University of North Carolina (UNC) to support a proposed 180-patient, randomized, placebo-controlled trial in trauma patients   Proposed investigator sponsored trial to evaluate the

ACER